Kwality Pharmaceuticals Ltd posts Rs. 6.23 crore consolidated PAT in Q2 FY2023-24

Kwality Pharmaceuticals Ltd has reported Consolidated financial results for the period ended September 30, 2023.

Financial Results (Q2 FY2024) - QoQ Comparison

The company has reported total income of Rs. 69.8830 crores during the period ended September 30, 2023 as compared to Rs. 67.8461 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs. 6.23587 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs. 5.4233 crores for the period ended June 30, 2023.

The company has reported EPS of Rs. 5.99 for the period ended September 30, 2023 as compared to Rs. 5.10 for the period ended June 30, 2023.

Financials	Q2 FY2024	Q1 FY2024	% Change
Total Income	₹ 69.8830 crs	₹67.8461 crs	3.00%
Net Profit	₹6.23587 crs	₹5.4233 crs	14.98%
EPS	₹5.99	₹5.10	17.45%

Financial Results (Q2 FY2024) - YoY Comparison

The company has reported total income of Rs. 69.8830 crores during the period ended September 30, 2023 as compared to Rs.56.9343 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs.6.23587 crores for the period ended September 30, 2023 as against net profit / (loss) of Rs.9.3925 crores for the period ended September 30, 2022.

The company has reported EPS of Rs.5.99 for the period ended September 30, 2023 as compared to Rs.8.82 for the period ended September 30, 2022.

Financials	Q2 FY2024	Q2 FY2023	% Change
Total Income	₹ 69.8830 crs	₹56.9343 crs	22.74%
Net Profit	₹6.23587 crs	₹9.3925 crs	-33.61%
EPS	₹5.99	₹8.82	-32.09%

Financial Results (Half Year Ended FY2024) - YoY Comparison

The company has reported total income of Rs.137.7291 crores during the 6 Months period ended September 30, 2023 as compared to Rs.127.1529 crores during the 6 Months period ended September 30, 2022.

The company has posted net profit / (loss) of Rs.11.6591 crores for the 6 Months period ended September 30, 2023 as against net profit / (loss) of Rs.19.5640 crores for the 6 Months period ended September 30, 2022.

The company has reported EPS of Rs.11.20 for the 6 Months period ended September 30, 2023 as compared to Rs.18.56 for the 6 Months period ended September 30, 2022.

Financials	Half Year Ended FY2024	Half Year Ended FY2023	% Change
Total Income	₹137.7291 crs	₹127.1529 crs	8.32%
Net Profit	₹11.6591 crs	₹19.5640 crs	-40.41%
EPS	₹11.20	₹18.56	-39.66%

Shares of Kwality Pharmaceuticals Ltd was last trading in BSE at Rs. 339.25 as compared to the previous close of Rs. 334.30. The total number of shares traded during the day was 7492 in over 229 trades.

The stock hit an intraday high of Rs. 350.00 and intraday low of 336.50. The net turnover during the day was Rs. 2582670.00.

Source : Equity Bulls

Keywords

KwalityPharmaceuticals Q2FY24 H1FY24 ResultUpdate